PaxMedica rises on Malawi's request for access to sleeping sickness drug

Kuvatris Therapeutics

17/04/2024 24:18

** Drug developer PaxMedica's  PXMD.O  shares rise 9.1% to
72 cents in extended trading
    ** PXMD says it has received Malawi health ministry's urgent
request for emergency access to IV suramin
    ** Suramin is used to treat sleeping sickness
    ** Company recently announced it has completed execution of
three pivotal registration/validation batches of PAX-101 (an IV
form of suramin)
    ** Company will file marketing application for drug with
U.S. FDA 
    ** Up to last close, stock down 12.8% YTD

    

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))